Please ensure Javascript is enabled for purposes of website accessibility

Genevant Sciences

Mar 4, 2026

Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute

Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle a long-running legal fight over the technology that made […]


Top Legal News

See All Top Legal News

Commentary

See All Commentary